Trishna Goswami

Company: In8Bio

Job title: Chief Medical Officer

Seminars:

Panel Discussion: Is Prioritizing Combination Therapy Over Monotherapy the Most Promising Avenue for Overcoming Heterogeneity? 4:30 pm

Understand the shortfalls of key therapy types with regard to targeting tumor heterogeneity and how combination therapies can be used to strategically overcome these Combine drug treatments with radiotherapy or tumor treating fields Are combination therapies considered ‘too risky’ from a regulatory standpoint? Understand how the regulatory framework can best support the approval of combination…Read more

day: Conference Day 1

Leveraging Engineered Gamma-Delta T Cells for Enhanced Tumor Cell Destruction in GBM 2:00 pm

Overcoming challenges of antigen selection with engineered T-cells for GBM tumor destruction Using gamma-delta T cells to combine an innate and adaptive immune response in GBM Determining the best combinatorial approach for cell therapy in solid tumorsRead more

day: Conference Day 2